106 related articles for article (PubMed ID: 1574245)
1. T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.
Kaver I; Pecht M; Trainin N; Greenstein A; Braf Z
Oncology; 1992; 49(2):108-13. PubMed ID: 1574245
[TBL] [Abstract][Full Text] [Related]
2. [RBC and T lymphocyte subsets in patients with bladder carcinoma: immunological study].
Xu J; Zhang Y
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):113-6. PubMed ID: 11829798
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Shi B; Qi J
J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
[TBL] [Abstract][Full Text] [Related]
4. Characterization of peripheral blood T-cell subpopulation of bladder cancer patients.
Greenstein A; Pecht M; Kaver I; Trainin N; Braf Z
Urol Res; 1991; 19(4):219-22. PubMed ID: 1926656
[TBL] [Abstract][Full Text] [Related]
5. Double Positive CD4
Bohner P; Chevalier MF; Cesson V; Rodrigues-Dias SC; Dartiguenave F; Burruni R; Tawadros T; Valerio M; Lucca I; Nardelli-Haefliger D; Jichlinski P; Derré L
Front Immunol; 2019; 10():622. PubMed ID: 30984190
[TBL] [Abstract][Full Text] [Related]
6. Distribution of CD1a-positive Langerhans cells and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1995 Dec; 177(4):401-6. PubMed ID: 8568595
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma.
Soygür T; Bedük Y; Yaman O; Yilmaz E; Tokgöz G; Gögüş O
Urology; 1999 Jan; 53(1):88-91. PubMed ID: 9886594
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.
Kastelan Z; Lukac J; Derezić D; Pasini J; Kusić Z; Sosić H; Kastelan M
Anticancer Res; 2003; 23(6D):5185-9. PubMed ID: 14981987
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients.
Gaafar T; Lotfy M; el Ridi R
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):511-7. PubMed ID: 1726772
[TBL] [Abstract][Full Text] [Related]
11. PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival.
Hou W; Xue M; Shi J; Yang M; Zhong W; Fan X; Zeng H; Lai Y; Huang J; Wang B; Lin T
Urol Oncol; 2020 Aug; 38(8):685.e1-685.e10. PubMed ID: 32409198
[TBL] [Abstract][Full Text] [Related]
12. [Lymphocytic subsets of tumor tissue, non tumorous kidney, and the peripheral blood in primary renal cell carcinoma].
Nagase Y; Moriyama N; Hosaka Y; Higashihara E; Murahashi I; Aso Y
Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1781-9. PubMed ID: 1762268
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 alpha and interleukin-1 beta production in peripheral whole blood from patients with urological cancer.
Kuo JY; Ohmoto Y; Yoshida O
Hinyokika Kiyo; 1998 Jun; 44(6):397-402. PubMed ID: 9719938
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
15. [Intravesical instillation of BCG for the bladder cancer: relationship between effect and immune cells in peripheral blood and bladder wall].
Chen LZ
Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):336-8. PubMed ID: 8313752
[TBL] [Abstract][Full Text] [Related]
16. [Two-color flow cytometric analysis of lymphocytic subsets in renal cell carcinoma].
Nagase Y; Moriyama N; Kurimoto S; Hosaka Y; Tajima A; Higashihara E; Aso Y
Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):281-8. PubMed ID: 8121110
[TBL] [Abstract][Full Text] [Related]
17. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
19. The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients.
Reyes E; Carballido J; Manzano L; Moltó L; Olivier C; Alvarez-Mon M
Br J Cancer; 1999 Mar; 79(7-8):1162-7. PubMed ID: 10098752
[TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte subsets in the peripheral blood of patients with renal cell carcinoma.
Mitropoulos D; Alamanis C; Deliveliotis C; Zervas A; Tzirakis A; Dimopoulos C
Acta Urol Belg; 1995 Sep; 63(3):21-5. PubMed ID: 7484518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
